User:Spmabel24/MontanaNeuroscience Institute

Montana Neuroscience Institute
'''"The study of the human brain and its disease remains one of the greatest scientific and philosophical challenges ever undertaken." - Floyd E. Bloom.2007'''

Mission
Bringing innovations in science and medicine to those suffering from brain injuries and diseases of the central nervous system.

About
The Montana Neuroscience Institute is a unique collaboration between The University of Montanaand St. Patrick Hospital and Health Sciences Center.The Institute operates as an independent non-profit 501(c)(3) corporation in Missoula, Montana. Both companies assist the Institute in fulfilling it's primary goal, to connect research conducted at the "bench" to care provided at the "bedside." The connection is best described by the three areas of expertise: clinical trials, translational research, and educational outreach.

Clinical Trials
Working with leaders in Industry, patients in Montana obtain access to the most current drugs,devices, and therapies available for central nervous system injury and disease. The Institute makes an effort to continually offer clinical trials for the following diseases: Multiple Sclerosis,Parkinson's disease,Alzheimer's,pain,epilepsy,neurosurgical devices, diabetic peripheral neuropathy, post-herptic neuralgia. Other clinical trials offered at the Institute include: obesity,diabetes, and women's studies.

Investigator initiated trials are also conducted at the Montana Neuroscience Institute.Investigator Initiated means a local physician(s) has developed an original idea that may be helpful for those suffering from a specific condition. Because these are original ideas developed by local doctors, there are no specific set of diseases that are studied regularly. However, the Institute regularly has at least three on-going investigator-initiated trials.

The staff at the Institute have over twenty years experience combined. Clinical Research Coordinators are attentive, patient, and coordinate with Doctors to ensure patients receive the best possible care while on the trial. All medical record data is kept confidential,regularly meeting and exceeding the regulations established by HIPAA.

Translational Research
The Center for Structural and Functional Neuroscience at the University of Montanais one of the departments on campus that focuses on translational research. Since its inception roughly ten years ago, the translational research at the University of Montana has grown into a nationally prominent leader. Current research at the University yields exciting results for patients with ALS,stroke,auditory disorders,brain trauma,epilepsy,and retinal disorders. With translational research, scientists are pursuing innovations in central nervous system injury and disease each day.

Some of the research, specifically Dave Poulsen,Ph.D., has moved from translational research into Phase 1 clinical trial with humans. You can find more information at Sinapis Pharma.

The Public Lecture Series
Providing education to patients,families,and caregivers within Missoula is a focal point for the Institute. The Public Lecture Series is always free and open to the public.Speakers for these events range from nationally renowned to local leaders within the industry.The topics are usually discussing diseases of the central nervous system (Multiple Sclerosis, Parkinson's disease, Alzheimer's, pain, ALS, stroke,etc) and always contain a component addressing new research and new treatment options. The Institute makes an effort to provide at least four public lectures per year, all covering different topics.